BackgroundThe 10-valent pneumococcal conjugate vaccine (PCV10) was introduced in Kenya in 2011. Introduction of any PCV will perturb the existing pneumococcal population structure, thus the aim was to genotype pneumococci collected in Kilifi before PCV10.Methods and FindingsUsing multilocus sequence typing (MLST), we genotyped >1100 invasive and carriage pneumococci from children, the largest collection genotyped from a single resource-poor country and reported to date. Serotype 1 was the most common serotype causing invasive disease and was rarely detected in carriage; all serotype 1 isolates were members of clonal complex (CC) 217. There were temporal fluctuations in the major circulating sequence types (STs); and although 1-3 major serot...
Pneumococcal conjugate vaccines (PCV) reduce nasopharyngeal carriage of vaccine-serotype pneumococci...
There are concerns that pneumococcal conjugate vaccines (PCVs) in sub-Saharan Africa sub-optimally i...
Background: To understand and model the impact of pneumococcal conjugate vaccines at the population ...
BACKGROUND: The 10-valent pneumococcal conjugate vaccine (PCV10) was introduced in Kenya in 2011. In...
The 10-valent pneumococcal conjugate vaccine (PCV10) was introduced in Kenya in 2011. Introduction o...
Background The 10-valent pneumococcal conjugate vaccine (PCV10) was introduced in Kenya in 2011. Int...
<div><p>Background</p><p>The 10-valent pneumococcal conjugate vaccine (PCV10) was introduced in Keny...
IntroductionPneumococcal infections cause a high death toll in Sub Saharan Africa (SSA) but the rece...
Background The eff ect of 7-valent pneumococcal conjugate vaccine (PCV) in developed countries was e...
BackgroundPneumococci are spread by persons with nasopharyngeal colonization, a necessary precursor ...
Streptococcus pneumoniae causes substantial mortality among children under 5-years-old worldwide. Po...
INTRODUCTION: Pneumococcal infections cause a high death toll in Sub Saharan Africa (SSA) but the re...
BACKGROUND: Streptococcus pneumoniae serotype 5 is among the most common serotypes causing invasive ...
SummaryBackgroundThe effect of 7-valent pneumococcal conjugate vaccine (PCV) in developed countries ...
Many African counties, like Kenya, have introduced pneumococcal conjugate vaccines (PCVs) with finan...
Pneumococcal conjugate vaccines (PCV) reduce nasopharyngeal carriage of vaccine-serotype pneumococci...
There are concerns that pneumococcal conjugate vaccines (PCVs) in sub-Saharan Africa sub-optimally i...
Background: To understand and model the impact of pneumococcal conjugate vaccines at the population ...
BACKGROUND: The 10-valent pneumococcal conjugate vaccine (PCV10) was introduced in Kenya in 2011. In...
The 10-valent pneumococcal conjugate vaccine (PCV10) was introduced in Kenya in 2011. Introduction o...
Background The 10-valent pneumococcal conjugate vaccine (PCV10) was introduced in Kenya in 2011. Int...
<div><p>Background</p><p>The 10-valent pneumococcal conjugate vaccine (PCV10) was introduced in Keny...
IntroductionPneumococcal infections cause a high death toll in Sub Saharan Africa (SSA) but the rece...
Background The eff ect of 7-valent pneumococcal conjugate vaccine (PCV) in developed countries was e...
BackgroundPneumococci are spread by persons with nasopharyngeal colonization, a necessary precursor ...
Streptococcus pneumoniae causes substantial mortality among children under 5-years-old worldwide. Po...
INTRODUCTION: Pneumococcal infections cause a high death toll in Sub Saharan Africa (SSA) but the re...
BACKGROUND: Streptococcus pneumoniae serotype 5 is among the most common serotypes causing invasive ...
SummaryBackgroundThe effect of 7-valent pneumococcal conjugate vaccine (PCV) in developed countries ...
Many African counties, like Kenya, have introduced pneumococcal conjugate vaccines (PCVs) with finan...
Pneumococcal conjugate vaccines (PCV) reduce nasopharyngeal carriage of vaccine-serotype pneumococci...
There are concerns that pneumococcal conjugate vaccines (PCVs) in sub-Saharan Africa sub-optimally i...
Background: To understand and model the impact of pneumococcal conjugate vaccines at the population ...